Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.28%41.59B | 7.95%40.27B | -3.27%16.06B | 13.79%8.55B | 10.78%37.3B | 8.11B | 1.96%5.08B | 23.57%16.61B | 10.52%7.51B | 3.59%33.67B |
| Cost of revenue | 3.06%30.19B | 7.14%29.29B | -4.55%10.11B | 14.22%6.21B | 12.06%27.34B | 6.5B | 3.83%4.81B | 26.87%10.59B | 14.28%5.44B | 2.17%24.4B |
| Gross profit | 3.85%11.4B | 10.18%10.98B | -1.01%5.96B | 12.69%2.34B | 7.42%9.97B | 1.61B | -23.25%263.74M | 18.14%6.02B | 1.74%2.07B | 7.53%9.28B |
| Operating expense | 5.13%8.55B | 12.62%8.13B | 1.32%1.86B | 16.19%1.78B | 5.99%7.22B | 2.04B | 13.74%1.81B | 11.42%1.83B | -1.00%1.53B | 8.31%6.81B |
| Staff costs | 1.28%5.17B | 9.06%5.11B | ---- | ---- | 4.21%4.68B | ---- | ---- | ---- | ---- | 7.03%4.49B |
| Other operating expenses | 11.62%3.38B | 19.18%3.02B | ---- | ---- | 9.44%2.54B | ---- | ---- | ---- | ---- | 10.87%2.32B |
| Operating profit | 0.22%2.86B | 3.79%2.85B | -2.04%4.1B | 2.80%557.37M | 11.38%2.75B | -431.83M | -23.90%-1.55B | 21.35%4.19B | 10.34%542.2M | 5.43%2.47B |
| Net non-operating interest income (expenses) | -68.93%-88.99M | -3.62%-52.68M | -12.91%-18.57M | -18.84%-10.89M | -27.22%-50.84M | -12.02M | -17.88%-13.2M | -49.43%-16.45M | -8.72%-9.17M | 7.43%-39.96M |
| Non-operating interest income | 910.00%3.43M | 319.75%340K | -39.39%20K | -11.11%16K | 39.66%81K | --16K | 75.00%14K | 83.33%33K | -25.00%18K | 70.59%58K |
| Non-operating interest expense | 74.32%92.42M | 4.12%53.02M | 12.81%18.59M | 18.78%10.91M | 27.24%50.92M | --12.03M | 17.92%13.22M | 49.49%16.48M | 8.62%9.19M | -7.36%40.02M |
| Net investment income | -29.95%147.21M | 39.34%210.15M | -1.63%37.88M | 11.08%13.75M | -6.86%150.81M | 83.57M | -18.25%16.35M | -0.71%38.51M | 385.45%12.38M | 15.74%161.92M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -4.78%-77.69M | 56.02%-74.15M | -91.48%-168.59M | 0 | -286.58%-141.42M | -635.14%-88.05M | ||||
| Income from associates and other participating interests | 36.81%97.88M | -47.41%71.54M | -54.10%-59.43M | -38.65%-99.2M | -2.03%136.05M | 158.37M | 30.40%87.8M | -17.82%-38.57M | -13.68%-71.55M | 4.88%138.86M |
| Special income (charges) | -966.33%-41.14M | 95.29%-3.86M | 97.82%-2.22M | -100.09%-43K | -1,182.67%-81.92M | -6.37M | -381.40%-21.25M | -10,691.24%-102.19M | 47.89M | 77.61%-6.39M |
| Less:Other special charges | 966.33%41.14M | 117.31%3.86M | 959.05%2.22M | 100.09%43K | -449.05%-22.29M | --77K | 473.27%25.3M | --210K | ---47.89M | -77.61%6.39M |
| Less:Write off | ---- | --0 | ---- | ---- | --104.22M | --6.29M | ---4.06M | ---- | ---- | --0 |
| Other non-operating income (expenses) | 291.26%17.47M | -120.65%-9.13M | -424.57%-53.5M | -84.73%1.71M | 144.75%44.22M | 13.31M | -55.69%3.25M | 396.99%16.48M | 298.84%11.18M | 495.45%18.07M |
| Income before tax | -2.70%2.91B | 7.79%2.99B | -1.03%4.01B | -13.18%462.69M | 4.75%2.78B | -194.96M | -47.66%-1.62B | 17.98%4.06B | 27.64%532.93M | 3.88%2.65B |
| Income tax | 0.75%1.08B | 17.71%1.07B | -5.00%1.28B | -8.82%202.76M | 0.84%909.76M | -183.63M | -45.28%-472.51M | 24.75%1.34B | 20.41%222.36M | 12.18%902.23M |
| Net income | -4.62%1.83B | 2.94%1.92B | 0.93%2.74B | -16.30%259.93M | 6.77%1.87B | -11.34M | -48.67%-1.15B | 14.89%2.71B | 33.37%310.56M | 0.05%1.75B |
| Net income continuous operations | -4.62%1.83B | 2.94%1.92B | 0.93%2.74B | -16.30%259.93M | 6.77%1.87B | ---11.34M | -48.67%-1.15B | 14.89%2.71B | 33.37%310.56M | 0.05%1.75B |
| Noncontrolling interests | 53.96%29.1M | 6.92%18.9M | -3.24%23.79M | -46.19%-2.97M | -11.42%17.68M | 147K | -337.51%-5.02M | -4.45%24.58M | -76.63%-2.03M | 17.74%19.96M |
| Net income attributable to the company | -5.21%1.8B | 2.91%1.9B | 0.97%2.71B | -15.90%262.9M | 6.98%1.85B | -11.48M | -47.61%-1.14B | 15.10%2.69B | 33.58%312.6M | -0.12%1.73B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -5.21%1.8B | 2.91%1.9B | 0.97%2.71B | -15.90%262.9M | 6.98%1.85B | -11.48M | -47.61%-1.14B | 15.10%2.69B | 33.58%312.6M | -0.12%1.73B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -5.39%99.09 | 2.50%104.73 | 0.75%149.7 | -15.91%14.53 | 6.97%102.18 | -0.64 | -47.55%-63.05 | 15.08%148.59 | 33.54%17.28 | -0.31%95.52 |
| Diluted earnings per share | -5.39%99.09 | 2.50%104.73 | 0.36%149.124 | -15.91%14.53 | 6.97%102.18 | -0.64 | -47.56%-63.0514 | 15.10%148.5858 | 33.54%17.28 | -0.31%95.52 |
| Dividend per share | 18.92%44 | 19.35%37 | 0 | 0 | 10.71%31 | 31 | 0 | 0 | 0 | 100.00%28 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |